Toxicogenomics in drug safety assessment.
作者信息
Hewitt Philip, Walijew Alexandra
机构信息
eTox, Institute of Toxicology, Merck Serono Research, Frankfurterstrasse 250, 64293 Darmstadt, Germany.
出版信息
Pharmacogenomics. 2008 Apr;9(4):379-82. doi: 10.2217/14622416.9.4.379.
PMID:18384252
Abstract
摘要
相似文献
1
Toxicogenomics in drug safety assessment.
Pharmacogenomics. 2008 Apr;9(4):379-82. doi: 10.2217/14622416.9.4.379.
2
Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.毒理基因组学与安全特征的未来：平衡公众对数据的获取与药物研发中的专利保护。
Pharmacogenomics. 2007 May;8(5):425-30. doi: 10.2217/14622416.8.5.425.
3
Omic profiling for drug safety assessment: current trends and public-private partnerships.用于药物安全性评估的组学分析：当前趋势与公私合作关系
Drug Discov Today. 2009 Apr;14(7-8):337-42. doi: 10.1016/j.drudis.2009.02.001.
4
SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational models.SimuGen有限公司：通过毒理基因组学、人类细胞培养和计算模型实现可靠的药物毒性早期预测。
Pharmacogenomics. 2007 Aug;8(8):1081-4. doi: 10.2217/14622416.8.8.1081.
5
Advances in toxicogenomics.毒理基因组学的进展。
Chem Res Toxicol. 2005 Mar;18(3):403-14. doi: 10.1021/tx0496690.
6
Iconix Biosciences, Inc.艾康尼克生物科学公司
Pharmacogenomics. 2007 Apr;8(4):401-5. doi: 10.2217/14622416.8.4.401.
7
Toxicogenomics in drug discovery and development -- making an impact.毒理基因组学在药物研发中的应用——产生影响。
Altern Lab Anim. 2009 Sep;37 Suppl 1:33-7. doi: 10.1177/026119290903701S11.
8
Regulatory acceptance of toxicogenomics data.毒理基因组学数据的监管认可。
Environ Health Perspect. 2004 Aug;112(12):A663-4. doi: 10.1289/ehp.112-1277121.
9
Toxicogenomics data: the road to acceptance.毒理基因组学数据：被接受之路。
Environ Health Perspect. 2004 Aug;112(12):A678-85. doi: 10.1289/ehp.112-a678.
10
Toxicogenomics in genetic toxicology and hazard determination--concluding remarks.遗传毒理学与危害判定中的毒理基因组学——结束语
Mutat Res. 2005 Aug 4;575(1-2):116-7. doi: 10.1016/j.mrfmmm.2005.02.008.
Zotero 插件